| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |